Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Vaginal cancer detected more often with PET than CT scans

24.06.2005


In patients with vaginal cancer, PET scans detected twice as many primary tumors and cancerous lymph nodes as did CT scans, according to researchers at Washington University School of Medicine in St. Louis. At this time, however, Medicaid, Medicare and many private insurers specify CT (computed tomography) for diagnosing and monitoring this cancer.



The researchers hoping to encourage a change in that standard report their comparison of the two methods in the July 1 issue of the International Journal of Radiation Oncology, Biology, Physics.

Like cervical cancer, vaginal cancer advances predictably, spreading to lymph nodes increasingly higher up in the body as the disease progresses. Doctors use information about the size of the tumor and the involvement of lymph nodes to determine treatment, such as where to target radiation and whether to use surgery or chemotherapy.


The results of this study suggest that the use of PET, or positron emission tomography, would make diagnosis of vaginal cancer much more accurate and allow better selection of treatment, according to study author Perry W. Grigsby, M.D., professor of radiation oncology and radiology.

However, until the procedure is reviewed and approved by the Centers for Medicaid and Medicare Services (CMS), vaginal cancer patients will most likely not be evaluated using PET scans.

CMS policies set standards often followed by private health insurance companies and therefore strongly determine what procedures physicians use. Studies such as this one play an essential role in CMS acceptance of new procedures.

"In 1999, we began publishing papers showing that PET scans picked up more cancerous lymph nodes in patients with cervical cancer," Grigsby says. "Armed with data from these kinds of studies, I went to Washington in 2003 to petition CMS to approve the use of PET scans for diagnosis of cervical cancer. In January of 2005, the procedure was approved for cervical cancer."

Several other cancers, in addition to cervical cancer, can be diagnosed and monitored using PET scans as the result of CMS acceptance. Grigsby is now working to persuade CMS that PET scans will improve the diagnosis and treatment of vaginal cancer.

"CT scans are useful in many cases, but they have a limit to their resolution," says Grigsby, who sees patients at the Siteman Cancer Center and is affiliated with Barnes-Jewish and St. Louis Children’s Hospitals. "When you’re evaluating lymph nodes for cancer using CT, the node has to be at least a centimeter for it to be considered abnormal. But PET scans can detect much smaller nodes that have cancerous cells."

PET scans are effective for this purpose because they use a different detection method than CT scans. CT scans obtain cross-sectional views of the body by detecting the amount of X-rays that pass through the body’s tissues. Small tumors can easily escape detection.

On the other hand, PET scans detect radioactivity that emanates directly from a tumor after a patient has received a dose of radioactive glucose, which accumulates in tumors. Even tiny tumors will collect enough "hot" glucose to show up on the PET scan.

Vaginal cancer is very similar to cervical cancer; both are linked to the presence of human papillomavirus. About 1 percent of gynecological malignancies are vaginal. The rates of survival with vaginal cancer are considered to be similar to those of cervical cancer.

According to Grigsby, if cervical cancer has not spread beyond its primary site, about 90 percent of patients will survive. The rate of survival drops to 70 percent if the cancer has spread to lymph nodes in the pelvis. The next stage of progression, in which the cancer has spread to nodes near the heart, has a survival rate of 30 to 40 percent. After that, untreated cervical cancer will move to nodes near the collar bone and will not be survivable.

"It is very important to know at the time of diagnosis, for both cervical and vaginal cancer, not only what the patient has in the pelvis, but where the tumor has spread," Grigsby says. "That will absolutely determine the kind of treatment."

Gwen Ericson | EurekAlert!
Further information:
http://www.wustl.edu

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>